On Demand 2019 ACAAI ASM Saturday Sessions
This collection covers general sessions from Saturday's program. This includes plenaries, symposia, and workshops. The sessions listed below are included in this package:
- Presidential Plenary Session: Adapting to New Evidence
- Practical Use and Effectiveness of New Digital Health Technologies in Effective Treatment of Asthma
- Prevention of Allergic Conditions: What Conversations to Have with Expecting Parents
- The Challenges of Infant Food Allergy and Anaphylaxis
- When Drugs Go Wild!
- Advances in the Care of Patients with Common Variable Immune Deficiency (CVID)
- Evolution of Food Allergy Therapies
- Integrative Approaches to Office Health: Improving Patient Outcomes
- New Frontiers: COPD, ACO, and Adults with Wheezing
- Racial, Ethnic, and Socioeconomic Disparities in Food Allergy
- The Changing Face of an Allergy Practice
- Cannabis in 2019: Navigating Our Patients Through Facts and Misconceptions
- Cough Across the Ages
- Coding and Governmental Regulations Update
- The Difficult to Control Atopic Dermatitis
- The Updated EoE Guidelines - Whose Disease is it Anyway?
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 21.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Of the AMA PRA Category 1 Credits™ listed above, the ABAI has designated a maximum of 3 credits as meeting the requirements for MOC Part II Self-Assessment.
Medical professionals who treat patients with allergic and/or immunological conditions:
- Practicing allergist/immunologists
- Allergy/immunology Fellows-in-Training
- Physician assistants
- Nurses and advanced practice nurses
- Allied health professionals
- Primary care physicians
- Other medical professionals
Upon completion of this session, participants should be able to:
- Apply evidence surrounding medical treatment and elimination diets in the management of patients with eosinophilic esophagitis.
- Identify patients at risk for having red meat allergy.
- Appreciate the role of epithelial dysfunction in the pathophysiology of asthma.
- Explain how the use of new digital technologies help risk-assess the poorly controlled asthma patient.
- Assess in a patient with uncontrolled asthma the potential use of new digital technology aids in improving outcomes.
- Review the use of new technological aids in monitoring patients with severe uncontrolled asthma.
- Determine which patients referred to them for diagnosis of food allergy require an oral challenge to confirm or refute the same.
- Perform an oral challenge in their office with confidence and supported by best evidence.
- Diagnose and manage infant anaphylaxis.
- Understand the evidence surrounding interventions in expectant mothers and newborns that attenuate the development of allergic conditions.
- Implement active conversations and anticipatory guidance with expecting parents.
- Appreciate the various forms of misinformation parents receive from online resources, friends and family members.
- Describe the histopathology of severe cutaneous drug eruptions.
- Recognize the appearance of severe cutaneous drug eruptions.
- Conduct skin testing, challenges or desensitization.
- Understand how to assess lung function in CVID patients.
- Identify the role of genetic diagnosis in the care and treatment of patients with CVID.
- Recognize the role of biologics for treating complications of CVID.
- Differentiating OIT from EPIT efficacy and safety.
- Understand impediments for implementation of these therapies.
- Identify frequently asked questions regarding these therapies.
- Outline the unhealthy habits in their A/I clinics that lead to physician and clinical team burnout and poor patient outcomes.
- Identify tools to help navigate the chaotic daily life of an allergy clinic with proven integrative medicine techniques to benefit the entire office team.
- Understand how a healthy provider and office improves patient outcomes through evidence-based literature review.
- Categorize the treatment of COPD patients in an allergy/immunology practice setting, utilizing GOLD Guidelines.
- Identify and treat patients with asthma-COPD overlap (ACO).
- Identify COPD patients who may benefit from immunodeficiency workup and treatment.
- Identify racial and ethnic disparities in food allergy prevalence.
- Describe socioeconomic disparities in food allergy.
- Understand potential differences in values clarification among racially and ethnically diverse food-allergic populations.
- Recognize how cannabis legalization impacts patient perceptions and use of the drug.
- Identify the effects of cannabis on the lungs.
- Recognize the potential symptoms and nuances of allergic sensitization to cannabis.
- Understand the role of the varied cough receptors in the pathogenesis of cough.
- Evaluate a patient with cough.
- Explain the mechanisms of action of therapeutic agents in the treatment of cough.
- Describe coding changes and updates relevant to allergy practice.
- Describe governmental and legislative updates relevant to allergists.
- Identify best-practice strategies for steroid, PPI and dietary management in EoE.
- Identify best-practice strategies for biologics and emerging potential therapies management in EoE.
- Identify best-practice strategies for shared management between GI and allergy in the care of patients with EoE.
Andrew Alexis, MD, MPH
William C. Anderson, MD
Susan R. Bailey, MD, FACAAI
Aleena Banerji, MD
Joseph A. Bellanti, MD, FACAAI
Bruce Bender, PhD
Leonard Bielory, MD, FACAAI
J. Andrew Bird, MD, FACAAI
Mark Boguniewicz, MD, FACAAI
Hannelore A. Brucker, MD, FACAAI
William Calhoun, MD, FACAAI
James Carmody, PhD
Warner W. Carr, MD, FACAAI
Mariana C. Castells, MD, PhD, FACAAI
Mario Castro, MD, MPH
Edmond S. Chan, MD
Jared Darveaux, MD
Anne K. Ellis, MD, MSc, FACAAI
Nabeel Farooqui, MD, FACAAI
Stanley M. Fineman, MD, MBA, FACAAI
David M. Fleischer, MD, FACAAI
Michael B. Foggs, MD, FACAAI
Lisa R. Forbes, MD
Alan B. Goldsobel, MD, FACAAI
Matthew Greenhawt, MD, MSc, MBA, FACAAI
Justin C. Greiwe, MD, FACAAI
Gary N. Gross, MD, FACAAI
Ruchi Gupta, MD, MPH
Nicola A. Hanania, MD, MS
Angela D. Hogan, MD, FACAAI
Stephen Holgate, MD, FACAAI
Randy J. Horwitz, MD, PhD
Stephen A. Imbeau, MD, FACAAI
Jeremy S. Katcher, MD, FACAAI
Rohit K. Katial, MD, FACAAI
Brian T. Kelly, MD, MA
Kevin Joseph Kelly, MD
David A. Khan, MD, FACAAI
Lisa J. Kobrynski, MD, MPH, FACAAI
Bruce J. Lanser, MD, FACAAI
Michael Levin, MD, PhD, FACAAI
Donald Y. Leung, MD, PhD, FACAAI
James T. Li, MD, PhD, FACAAI
Jay A. Lieberman, MD, FACAAI
Aidan A. Long, MD
Todd A. Mahr, MD, FACAAI
Bryan L. Martin, DO, FACAAI
Kevin P. McGrath, MD, FACAAI
Kevin R. Murphy, MD, FACAAI
David R. Naimi, DO
Anil Nanda, MD, FACAAI
Maeve E. O'Connor, MD, FACAAI
Princess Ogbogu, MD, FACAAI
John J. Oppenheimer, MD, FACAAI
Elena E. Perez, MD
Rachel Peters, MPH, PhD
Benjamin Prince, MD, MSci
Nikita Raje, MBBS, MSc
Allison C. Ramsey, MD, FACAAI
Matthew Rank, MD, FACAAI
Melinda M. Rathkopf, MD, FACAAI
John M. Routes, MD, FACAAI
Michael R. Rupp, MD, FACAAI
Marcus Shaker, MD, MSc, FACAAI
Meagan W. Shepherd, MD, FACAAI
Mandel R. Sher, MD, FACAAI
William S. Silvers, MD, FACAAI
Mark C. Stahl, DO, FACAAI
David R. Stukus, MD, FACAAI
James L. Sublett, MD, FACAAI
J. Wesley Sublett, MD, MPH, FACAAI
James M. Tracy, DO, FACAAI
Janna M. Tuck, MD, FACAAI
Carina Venter, PhD, RD
Brian P. Vickery, MD
Dana V. Wallace, MD, FACAAI
Julie Wang, MD, FACAAI
Cherie Y. Zachary, MD, FACAAI
Myron J. Zitt, MD, FACAAI
- 21.50 AMA PRA Category 1 Credit™
- 21.50 Attendance
- 21.50 CBRN
- 3.00 MOC